Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

In recent months, there’s been a real shift in people’s confidence and boldness when using colour in their homes. And that’s especially true when it comes to living room colour schemes. Most living ...

The end goal of the war against affirmative action is to return the US to a state of quasi-legal racial segregation.

Needham initiated a Buy rating for Absci (ABSI), noting its AI-powered drug discovery platforms, strategic partnerships, and ...

The Breville Barista Touch Impress has long held the number one spot in our guide to the best espresso machines thanks to its effortless automated dosing, grinding, tamping, and milk frothing, which ...

An infant’s poop typically changes color and consistency during the first few days, weeks, and months of life. A wide range of colors is usual. In infants, the main reasons for changes in stool ...

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target to $119.00. Discover outperforming stocks and invest ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...

In separate presentations, the CEOs of Bristol Myers Squibb, Pfizer and Merck laid out their plans to overcome high-profile losses of exclusivity (LOEs) slated to dent sales through the end of the ...

Merck & Co. expects to launch an easier-to-administer version of its blockbuster cancer treatment Keytruda before the end of the year, accelerating the company’s efforts to protect its top ...